• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂处方在老年非甾体抗炎药使用者中的治疗意图。

Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.

机构信息

Division of Gastroenterology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Aliment Pharmacol Ther. 2009 Sep 15;30(6):652-61. doi: 10.1111/j.1365-2036.2009.04085.x. Epub 2009 Jul 2.

DOI:10.1111/j.1365-2036.2009.04085.x
PMID:19573167
Abstract

BACKGROUND

Prescription of proton pump inhibitors (PPIs) has increased dramatically.

AIM

To assess therapeutic intent of PPI prescription among elderly veterans prescribed nonsteroidal anti-inflammatory drugs.

METHODS

Medical-record abstraction identified therapeutic intent of PPI prescription. An 'appropriate therapeutic intent' was defined as symptomatic gastro-oesophageal reflux disease or endoscopic oesophagitis, Zollinger-Ellison disease, dyspepsia, upper gastrointestinal event, Helicobacter pylori infection or nonsteroidal anti-inflammatory drug gastroprotection. Logistic regression predicted the outcome while adjusting for clinical characteristics.

RESULTS

Of 1491 patients [mean 73 years (s.d. 5.6), 73% white and 99.8% men], among those charts which did document a therapeutic indication, 88.8% were appropriate. Prior gastroscopy was predictive of an appropriate therapeutic intent (OR 2.7; 95% CI: 1.9-3.7). Prescription to patients who used VA pharmacy services only, to in-patients, or by a cardiologist or an otolaryngologist were less likely to be appropriate. Gastroprotection was poorly recognized as an indication for PPI prescription, except by rheumatologists (OR 46.7; 95% CI: 15.9-136.9), or among highly co-morbid patients (OR 1.8; 95% CI: 1.1-2.9). Among in-patients, 45% of PPI prescriptions were initiated for unknown or inappropriate reasons.

CONCLUSIONS

Type of provider predicts appropriate PPI use. In-patient prescription is associated with poor recognition of necessary gastroprotection and unknown therapeutic intent.

摘要

背景

质子泵抑制剂 (PPI) 的处方量大幅增加。

目的

评估在开具非甾体抗炎药的老年退伍军人中 PPI 处方的治疗意图。

方法

通过病历摘录确定 PPI 处方的治疗意图。“适当的治疗意图”定义为有症状的胃食管反流病或内镜食管炎、卓-艾综合征、消化不良、上消化道事件、幽门螺杆菌感染或非甾体抗炎药胃保护。使用逻辑回归预测结果,同时调整临床特征。

结果

在 1491 名患者中[平均年龄 73 岁(标准差 5.6),73%为白人,99.8%为男性],在记录治疗指征的病历中,88.8%是适当的。先前的胃镜检查可预测适当的治疗意图(OR 2.7;95%CI:1.9-3.7)。仅向使用 VA 药房服务的患者、住院患者、心脏病专家或耳鼻喉科医生开具处方不太可能是适当的。除了风湿病专家(OR 46.7;95%CI:15.9-136.9)或高度共病患者(OR 1.8;95%CI:1.1-2.9)外,胃保护作为 PPI 处方的指征认识不足。在住院患者中,45%的 PPI 处方是由于未知或不适当的原因而开具的。

结论

提供者的类型预测了 PPI 的适当使用。住院患者的处方与对必要胃保护和未知治疗意图的认识不足有关。

相似文献

1
Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.质子泵抑制剂处方在老年非甾体抗炎药使用者中的治疗意图。
Aliment Pharmacol Ther. 2009 Sep 15;30(6):652-61. doi: 10.1111/j.1365-2036.2009.04085.x. Epub 2009 Jul 2.
2
Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.国家医疗服务提供者为老年非甾体抗炎药使用者开具质子泵抑制剂(PPI)进行胃保护的有效性。
Am J Gastroenterol. 2008 Feb;103(2):323-32. doi: 10.1111/j.1572-0241.2007.01595.x.
3
Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
Clin Gastroenterol Hepatol. 2009 Aug;7(8):855-61. doi: 10.1016/j.cgh.2009.05.017. Epub 2009 May 22.
4
Reduced hospitalization cost for upper gastrointestinal events that occur among elderly veterans who are gastroprotected.老年退伍军人接受胃保护后上消化道事件住院费用降低。
Clin Gastroenterol Hepatol. 2010 Apr;8(4):350-6; quiz e45. doi: 10.1016/j.cgh.2010.01.002. Epub 2010 Jan 21.
5
Evaluation of use of proton pump inhibitors in Greece.希腊质子泵抑制剂使用情况评估。
Eur J Intern Med. 2009 Mar;20(2):171-3. doi: 10.1016/j.ejim.2007.10.020. Epub 2008 Jun 16.
6
[Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].[非甾体抗炎药治疗的有风险因素患者胃保护指征与处方差异分析:GAP研究]
Gastroenterol Hepatol. 2010 Feb;33(2):80-91. doi: 10.1016/j.gastrohep.2009.09.009. Epub 2009 Nov 22.
7
Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.出院后使用非甾体抗炎药的患者的胃保护措施。
Am J Ther. 2008 Sep-Oct;15(5):444-9. doi: 10.1097/MJT.0b013e31816a23c6.
8
Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).三大洲血液透析患者胃肠道药物处方的巨大差异:透析结局和实践模式研究(DOPPS)
Hemodial Int. 2006 Apr;10(2):180-8. doi: 10.1111/j.1542-4758.2006.00092.x.
9
National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use.近期使用非甾体抗炎药的老年退伍军人上消化道或心血管事件后的全国死亡率。
Aliment Pharmacol Ther. 2008 Jul;28(1):97-106. doi: 10.1111/j.1365-2036.2008.03706.x. Epub 2008 Apr 7.
10
Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.英国非甾体抗炎药长期使用者中质子泵抑制剂的联合处方情况。
Rheumatology (Oxford). 2008 Apr;47(4):458-63. doi: 10.1093/rheumatology/kem375. Epub 2008 Feb 7.

引用本文的文献

1
Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.未指明的质子泵抑制剂起始治疗与潜在慢性肾脏病患者不良结局风险:一项全国性、回顾性队列研究。
BMJ Open. 2024 Jan 29;14(1):e078032. doi: 10.1136/bmjopen-2023-078032.
2
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.质子泵抑制剂优化使用指南:PPI 管理。
Indian J Gastroenterol. 2023 Oct;42(5):601-628. doi: 10.1007/s12664-023-01428-7. Epub 2023 Sep 12.
3
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding.
质子泵抑制剂预防上消化道出血的指南使用障碍。
Ann Fam Med. 2022 Jan-Feb;20(1):5-11. doi: 10.1370/afm.2734.
4
Review of Proton Pump Inhibitor Overuse in the US Veteran Population.美国退伍军人人群中质子泵抑制剂过度使用情况综述
J Pharm Technol. 2015 Aug;31(4):167-176. doi: 10.1177/8755122515575177. Epub 2015 Mar 9.
5
Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats.大鼠口服醋氯芬酸和埃索美拉唑的药代动力学及抗胃溃疡活性
Pharmaceutics. 2018 Sep 6;10(3):152. doi: 10.3390/pharmaceutics10030152.
6
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.质子泵抑制剂在酸相关性疾病中的有效与安全治疗——一份探讨抑酸益处及潜在危害的立场文件
BMC Med. 2016 Nov 9;14(1):179. doi: 10.1186/s12916-016-0718-z.
7
Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.长期护理机构居民中 SSRI、非甾体抗炎药/阿司匹林和胃保护药物的同时使用:病历回顾。
Clin Drug Investig. 2011;31(5):337-44. doi: 10.1007/BF03256932.
8
Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents.质子泵抑制剂的使用及其在体弱老年疗养院居民中的相关风险。
Scand J Prim Health Care. 2010 Sep;28(3):154-9. doi: 10.3109/02813432.2010.493315.